Our approach to health is based on creating novel health solutions based on clinically tested strains with unique Mechanisms of Action. Our strain selection process involves the identification of a specific health target, followed by the selection of unique bacterial mechanisms of action for that application. The specific KABP™ clinical strains have shown a robust capability to survive under harsh gastro-intestinal tract (G.I.) conditions.
Find out about our full portfolio of formulations, including products for digestive, infant, cardiovascular, immune, cardiovascular, brain, and oral health at www.kanekaprobiotics.com.
Brands: Kaneka Probiotics • KABP™
Certifications & Quality Control Data:
(select all applicable) Certified Non-GMO, Offer Clean Label Solutions, Provide Formulation/R&D Support
Exporting Status: Yes
Geographic Area of Interest: Canada, United States